サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1634361

勃起不全（ED）治療薬の世界市場（2025年～2029年）

Global Erectile Dysfunction (ED) Drugs Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 200 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
勃起不全（ED）治療薬の世界市場（2025年～2029年）
出版日: 2025年01月07日
発行: TechNavio
ページ情報: 英文 200 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

勃起不全（ED）治療薬市場（2025年～2029年）

世界の勃起不全（ED）治療薬の市場規模は、2024年～2029年に15億300万米ドルに達し、予測期間中のCAGRは6.6%で成長すると予測されます。当レポートでは、勃起不全（ED）治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

本レポートは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ED治療薬に対する需要の高まり、EDに対する意識の高まり、EDを引き起こす疾患の有病率の高さによって牽引されています。

市場範囲
基準年 2025年
終了年 2029年
予測期間 2025年～2029年
成長モメンタム 加速
前年比2025年 6.3%
CAGR 6.6%
増分額 15億300万米ドル

本調査では、今後数年間の勃起不全（ED）治療薬市場の成長を促進する主な要因の1つとして、開発後期の新薬製剤の存在を挙げています。また、新規治療法開発のための研究開発の拡大や、OTC医薬品の乱用の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavioの分析

  • 価格感度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • ディスラプションの要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模（2024年）
  • 市場の見通し（2024年～2029年）

第5章 市場規模実績

  • 勃起不全（ED）治療薬の世界市場（2019年～2023年）
  • エンドユーザーセグメント分析（2019年～2023年）
  • 製品セグメント分析（2019年～2023年）
  • 地域セグメント分析（2019年～2023年）
  • 国セグメント分析（2019年～2023年）

第6章 定性分析

  • 世界の勃起不全（ED）市場におけるAIの影響

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 院内薬局：市場規模と予測（2024年～2029年）
  • 小売薬局：市場規模と予測（2024年～2029年）
  • オンライン薬局：市場規模と予測（2024年～2029年）
  • 市場機会：エンドユーザー別

第9章 市場セグメンテーション：製品別

  • 市場セグメント
  • 比較：製品別
  • 経口薬：市場規模と予測（2024年～2029年）
  • 外用薬：市場規模と予測（2024年～2029年）
  • その他：市場規模と予測（2024年～2029年）
  • 市場機会：製品別

第10章 顧客情勢

  • 顧客情勢の概要

第11章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測（2024年～2029年）
  • 欧州：市場規模と予測（2024年～2029年）
  • アジア：市場規模と予測（2024年～2029年）
  • 世界のその他の地域：市場規模と予測（2024年～2029年）
  • 米国：市場規模と予測（2024年～2029年）
  • カナダ：市場規模と予測（2024年～2029年）
  • ドイツ：市場規模と予測（2024年～2029年）
  • 中国：市場規模と予測（2024年～2029年）
  • インド：市場規模と予測（2024年～2029年）
  • 英国：市場規模と予測（2024年～2029年）
  • フランス：市場規模と予測（2024年～2029年）
  • 韓国：市場規模と予測（2024年～2029年）
  • 日本：市場規模と予測（2024年～2029年）
  • イタリア：市場規模と予測（2024年～2029年）
  • 市場機会：地域情勢別

第12章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第13章 競合情勢

  • 概要
  • 競合情勢
  • ディスラプションの状況
  • 業界のリスク

第14章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • Bayer AG
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • Futura Medical Plc
  • Innovcare Lifesciences Pvt. Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • SK Inc.
  • Teva Pharmaceutical Industries Ltd.
  • TTK Healthcare Ltd.
  • Viatris Inc.
  • VIVUS LLC

第15章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits11: Overview on criticality of inputs and factors of differentiation
  • Exhibits12: Overview on factors of disruption
  • Exhibits13: Impact of drivers and challenges in 2024 and 2029
  • Exhibits14: Parent Market
  • Exhibits15: Data Table on - Parent Market
  • Exhibits16: Market characteristics analysis
  • Exhibits17: Value chain analysis
  • Exhibits18: Offerings of companies included in the market definition
  • Exhibits19: Market segments
  • Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Historic Market Size - Data Table on Global Erectile Dysfunction (ED) Drugs Market 2019 - 2023 ($ million)
  • Exhibits25: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits29: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits35: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits36: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits37: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits38: Chart on Comparison by End-user
  • Exhibits39: Data Table on Comparison by End-user
  • Exhibits40: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits41: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits42: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits43: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits44: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits45: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits46: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits47: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits48: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits49: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits50: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits51: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits52: Market opportunity by End-user ($ million)
  • Exhibits53: Data Table on Market opportunity by End-user ($ million)
  • Exhibits54: Chart on Product - Market share 2024-2029 (%)
  • Exhibits55: Data Table on Product - Market share 2024-2029 (%)
  • Exhibits56: Chart on Comparison by Product
  • Exhibits57: Data Table on Comparison by Product
  • Exhibits58: Chart on Oral drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits59: Data Table on Oral drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits60: Chart on Oral drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits61: Data Table on Oral drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits62: Chart on Topical drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits63: Data Table on Topical drugs - Market size and forecast 2024-2029 ($ million)
  • Exhibits64: Chart on Topical drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits65: Data Table on Topical drugs - Year-over-year growth 2024-2029 (%)
  • Exhibits66: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits67: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits68: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits69: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits70: Market opportunity by Product ($ million)
  • Exhibits71: Data Table on Market opportunity by Product ($ million)
  • Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits75: Chart on Geographic comparison
  • Exhibits76: Data Table on Geographic comparison
  • Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits97: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Market opportunity By Geographical Landscape ($ million)
  • Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits135: Impact of drivers and challenges in 2024 and 2029
  • Exhibits136: Overview on criticality of inputs and factors of differentiation
  • Exhibits137: Overview on factors of disruption
  • Exhibits138: Impact of key risks on business
  • Exhibits139: Companies covered
  • Exhibits140: Company ranking index
  • Exhibits141: Matrix on companies position and classification
  • Exhibits142: Bayer AG - Overview
  • Exhibits143: Bayer AG - Business segments
  • Exhibits144: Bayer AG - Key news
  • Exhibits145: Bayer AG - Key offerings
  • Exhibits146: Bayer AG - Segment focus
  • Exhibits147: SWOT
  • Exhibits148: Cadila Pharmaceuticals Ltd. - Overview
  • Exhibits149: Cadila Pharmaceuticals Ltd. - Product / Service
  • Exhibits150: Cadila Pharmaceuticals Ltd. - Key offerings
  • Exhibits151: SWOT
  • Exhibits152: Cipla Inc. - Overview
  • Exhibits153: Cipla Inc. - Business segments
  • Exhibits154: Cipla Inc. - Key news
  • Exhibits155: Cipla Inc. - Key offerings
  • Exhibits156: Cipla Inc. - Segment focus
  • Exhibits157: SWOT
  • Exhibits158: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits159: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits160: Dr Reddys Laboratories Ltd. - Key news
  • Exhibits161: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits162: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits163: SWOT
  • Exhibits164: Eli Lilly and Co. - Overview
  • Exhibits165: Eli Lilly and Co. - Product / Service
  • Exhibits166: Eli Lilly and Co. - Key offerings
  • Exhibits167: SWOT
  • Exhibits168: Endo International Plc - Overview
  • Exhibits169: Endo International Plc - Business segments
  • Exhibits170: Endo International Plc - Key news
  • Exhibits171: Endo International Plc - Key offerings
  • Exhibits172: Endo International Plc - Segment focus
  • Exhibits173: SWOT
  • Exhibits174: Futura Medical Plc - Overview
  • Exhibits175: Futura Medical Plc - Product / Service
  • Exhibits176: Futura Medical Plc - Key offerings
  • Exhibits177: SWOT
  • Exhibits178: Innovcare Lifesciences Pvt. Ltd. - Overview
  • Exhibits179: Innovcare Lifesciences Pvt. Ltd. - Product / Service
  • Exhibits180: Innovcare Lifesciences Pvt. Ltd. - Key offerings
  • Exhibits181: SWOT
  • Exhibits182: Lupin Ltd. - Overview
  • Exhibits183: Lupin Ltd. - Business segments
  • Exhibits184: Lupin Ltd. - Key news
  • Exhibits185: Lupin Ltd. - Key offerings
  • Exhibits186: Lupin Ltd. - Segment focus
  • Exhibits187: SWOT
  • Exhibits188: Pfizer Inc. - Overview
  • Exhibits189: Pfizer Inc. - Product / Service
  • Exhibits190: Pfizer Inc. - Key news
  • Exhibits191: Pfizer Inc. - Key offerings
  • Exhibits192: SWOT
  • Exhibits193: SK Inc. - Overview
  • Exhibits194: SK Inc. - Product / Service
  • Exhibits195: SK Inc. - Key offerings
  • Exhibits196: SWOT
  • Exhibits197: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits198: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits199: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits200: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits201: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits202: SWOT
  • Exhibits203: TTK Healthcare Ltd. - Overview
  • Exhibits204: TTK Healthcare Ltd. - Product / Service
  • Exhibits205: TTK Healthcare Ltd. - Key offerings
  • Exhibits206: SWOT
  • Exhibits207: Viatris Inc. - Overview
  • Exhibits208: Viatris Inc. - Business segments
  • Exhibits209: Viatris Inc. - Key news
  • Exhibits210: Viatris Inc. - Key offerings
  • Exhibits211: Viatris Inc. - Segment focus
  • Exhibits212: SWOT
  • Exhibits213: VIVUS LLC - Overview
  • Exhibits214: VIVUS LLC - Product / Service
  • Exhibits215: VIVUS LLC - Key offerings
  • Exhibits216: SWOT
  • Exhibits217: Inclusions checklist
  • Exhibits218: Exclusions checklist
  • Exhibits219: Currency conversion rates for US$
  • Exhibits220: Research methodology
  • Exhibits221: Information sources
  • Exhibits222: Data validation
  • Exhibits223: Validation techniques employed for market sizing
  • Exhibits224: Data synthesis
  • Exhibits225: 360 degree market analysis
  • Exhibits226: List of abbreviations
目次
Product Code: IRTNTR72378

Erectile Dysfunction (ED) Drugs Market 2025-2029

The erectile dysfunction (ED) drugs market is forecasted to grow by USD 1503 mn during 2024-2029, accelerating at a CAGR of 6.6% during the forecast period. The report on the erectile dysfunction (ED) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for ED drugs, rising awareness of ED, and high prevalence of conditions resulting in ED.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.3%
CAGR6.6%
Incremental Value$1503 mn

Technavio's erectile dysfunction (ED) drugs market is segmented as below:

By End-user

    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy

By Product

    • Oral drugs
    • Topical drugs
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the presence of novel drug formulations in late stages of development as one of the prime reasons driving the erectile dysfunction (ED) drugs market growth during the next few years. Also, expanding research for development of novel therapies and increasing OTC abuse of drugs will lead to sizable demand in the market.

The report on the erectile dysfunction (ED) drugs market covers the following areas:

    • Erectile Dysfunction (ED) Drugs Market sizing
    • Erectile Dysfunction (ED) Drugs Market forecast
    • Erectile Dysfunction (ED) Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading erectile dysfunction (ED) drugs market vendors that include Bayer AG, Cadila Pharmaceuticals Ltd., Cipla Inc., Dong A Socio Holdings Co. Ltd., DR Reddys Laboratories Ltd., Eli Lilly and Co., Endo International PLC, Futura Medical PLC, Innovcare Lifesciences Pvt. Ltd., Lupin Ltd., Pfizer Inc., SK Inc., Teva Pharmaceutical Industries Ltd., TTK Healthcare Ltd., Viatris Inc., and VIVUS LLC. Also, the erectile dysfunction (ED) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Erectile Dysfunction (ED) Drugs Market 2019 - 2023
    • Historic Market Size - Data Table on Global Erectile Dysfunction (ED) Drugs Market 2019 - 2023 ($ million)
  • 5.2 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.3 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.4 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.5 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on the Global Erectile Dysfunction (ED) Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

  • 8.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 8.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 8.3 Hospital pharmacy - Market size and forecast 2024-2029
    • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.4 Retail pharmacy - Market size and forecast 2024-2029
    • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.5 Online pharmacy - Market size and forecast 2024-2029
    • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Product

  • 9.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 9.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 9.3 Oral drugs - Market size and forecast 2024-2029
    • Chart on Oral drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral drugs - Year-over-year growth 2024-2029 (%)
  • 9.4 Topical drugs - Market size and forecast 2024-2029
    • Chart on Topical drugs - Market size and forecast 2024-2029 ($ million)
    • Data Table on Topical drugs - Market size and forecast 2024-2029 ($ million)
    • Chart on Topical drugs - Year-over-year growth 2024-2029 (%)
    • Data Table on Topical drugs - Year-over-year growth 2024-2029 (%)
  • 9.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 11.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 11.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 11.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 11.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 11.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 11.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 11.11 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 11.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 11.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 11.14 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 11.15 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 11.16 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 11.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 14.5 Cadila Pharmaceuticals Ltd.
    • Cadila Pharmaceuticals Ltd. - Overview
    • Cadila Pharmaceuticals Ltd. - Product / Service
    • Cadila Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 14.6 Cipla Inc.
    • Cipla Inc. - Overview
    • Cipla Inc. - Business segments
    • Cipla Inc. - Key news
    • Cipla Inc. - Key offerings
    • Cipla Inc. - Segment focus
    • SWOT
  • 14.7 Dr Reddys Laboratories Ltd.
    • Dr Reddys Laboratories Ltd. - Overview
    • Dr Reddys Laboratories Ltd. - Business segments
    • Dr Reddys Laboratories Ltd. - Key news
    • Dr Reddys Laboratories Ltd. - Key offerings
    • Dr Reddys Laboratories Ltd. - Segment focus
    • SWOT
  • 14.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 14.9 Endo International Plc
    • Endo International Plc - Overview
    • Endo International Plc - Business segments
    • Endo International Plc - Key news
    • Endo International Plc - Key offerings
    • Endo International Plc - Segment focus
    • SWOT
  • 14.10 Futura Medical Plc
    • Futura Medical Plc - Overview
    • Futura Medical Plc - Product / Service
    • Futura Medical Plc - Key offerings
    • SWOT
  • 14.11 Innovcare Lifesciences Pvt. Ltd.
    • Innovcare Lifesciences Pvt. Ltd. - Overview
    • Innovcare Lifesciences Pvt. Ltd. - Product / Service
    • Innovcare Lifesciences Pvt. Ltd. - Key offerings
    • SWOT
  • 14.12 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 14.13 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 14.14 SK Inc.
    • SK Inc. - Overview
    • SK Inc. - Product / Service
    • SK Inc. - Key offerings
    • SWOT
  • 14.15 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT
  • 14.16 TTK Healthcare Ltd.
    • TTK Healthcare Ltd. - Overview
    • TTK Healthcare Ltd. - Product / Service
    • TTK Healthcare Ltd. - Key offerings
    • SWOT
  • 14.17 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus
    • SWOT
  • 14.18 VIVUS LLC
    • VIVUS LLC - Overview
    • VIVUS LLC - Product / Service
    • VIVUS LLC - Key offerings
    • SWOT

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations